425: Strive, Semler Scientific Merger Communication

Strive, Inc. reposted a communication regarding its proposed business combination with Semler Scientific, Inc., highlighting forward-looking statements and associated risks.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication, reposted by Strive's Chief Investment Officer, Ben Werkman, on December 29, 2025, serves as a cautionary statement regarding forward-looking information.
• Forward-looking statements include expectations for the transaction, anticipated strategic and financial benefits, the timing of closing, and the ability to successfully integrate the combined businesses.
• Investors are cautioned against relying too heavily on any forward-looking statements due to inherent risks and uncertainties.
• Additional information regarding the proposed transaction and the companies can be found in various SEC filings, including Strive's Form S-4 and 10-Q, and Semler Scientific's Form 10-Q and 8-K.

Sentiment

Score: 5

Explanation: The filing is a standard cautionary statement regarding a proposed merger. While it outlines potential benefits, it heavily emphasizes numerous risks and uncertainties, leading to a neutral sentiment. The tone is formal and legally mandated, not promotional.

Positives

• The proposed transaction aims to achieve strategic and financial benefits for the combined company.
• The companies anticipate successful integration of their businesses following the merger.

Negatives

• The proposed transaction may not close when expected or at all, as conditions to closing may not be met.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Integration of the two companies could be more difficult, time-consuming, or costly than initially anticipated.
• The transaction may be more expensive or take longer to complete than expected due to unforeseen factors.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Strive's issuance of additional Class A common stock in connection with the transaction will result in dilution for existing shareholders.
• There is a potential for adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing are a possibility.

Risks

• The occurrence of any event, change, or other circumstance that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the realization of anticipated benefits.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The companies express outlook and expectations regarding the proposed transaction, including anticipated strategic and financial benefits, the timing of closing, and the ability to successfully integrate the combined businesses. However, these forward-looking statements are subject to significant risks and uncertainties, and actual results could differ materially.

Management Comments

• Strive and Semler Scientific believe that their expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of their existing knowledge of their business and operations.

Industry Context

The filing mentions "Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets," indicating an engagement with emerging digital asset trends within corporate finance, which is a notable industry development that could influence strategic decisions and risk profiles for companies in various sectors.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a potential risk factor for the proposed transaction.

Stakeholder Impact

• Shareholders: Potential for dilution due to Strive's issuance of new shares; urged to review proxy materials for voting decisions; share price volatility before closing is a risk.
• Customers: Potential for adverse reactions or changes to business relationships as a result of the merger announcement or completion.
• Employees: Potential for changes to employee relationships following the merger announcement or completion.

Next Steps

• Strive and Semler Scientific will continue to work towards satisfying the conditions required for closing the proposed transaction.
• Stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus to make informed voting or investment decisions regarding the proposed transaction.
• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.

Key Dates

Keywords

Merger, Acquisition, Business Combination, Strive Inc, Semler Scientific, SEC Filing, Form 425, Forward-Looking Statements, Corporate Governance, Bitcoin Treasury, Digital Assets, Dilution, Risk Management